Literature DB >> 10517491

Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice.

T B Prigozhina1, O Gurevitch, S Slavin.   

Abstract

We recently described a new nonmyeloablative method to induce stable and specific transplantation tolerance to allogeneic tissues in adult mice. It included total lymphoid irradiation (TLI) of recipients with six fractions of 200 cGy each, inoculation with donor bone marrow (BM) cells and cyclophosphamide (Cy) for selective elimination or inactivation of residual donor-reactive cells of the host, and infusion with T-cell depleted donor BM cells after Cy. Here, we investigated the possibility to induce stable bilateral graft-vs-host and host-vs-graft transplantation tolerance using non-T-cell depleted allogeneic BM. Our results show that the dose of BM required for the induction of transplantation tolerance was inversely correlated with the intensity of the conditioning. Transfer of a low dose (3 x 10(6)) of total donor BM cells to recipients preconditioned with a less intensive regimen (two or three TLI fractions instead of six) diminished graft-vs-host disease (GVHD)-related mortality of recipients to 40% and converted 89% of the survivors into GVHD-free mixed hematopoietic chimeras that maintained donor skin allografts >180 days. A tenfold increase in the number of donor BM cells (3 x 10(7) instead of 3 x 10(6)) reduced the rate of GVHD-related mortality of recipients to 20% and resulted in bilateral transplantation tolerance in 100% of nonirradiated survivors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517491     DOI: 10.1016/s0301-472x(99)00088-0

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

Review 1.  Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation.

Authors:  Shimon Slavin
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 2.  Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.

Authors:  Tatyana Prigozhina; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

Review 3.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

Review 4.  Insights and hopes in umbilical cord blood stem cell transplantations.

Authors:  Somayeh Shahrokhi; Farid Menaa; Kamran Alimoghaddam; Colin McGuckin; Massoumeh Ebtekar
Journal:  J Biomed Biotechnol       Date:  2012-10-31

Review 5.  Treatment of systemic sclerosis: potential role for stem cell transplantation.

Authors:  Wen Xiong; Chris T Derk
Journal:  Stem Cells Cloning       Date:  2009-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.